Evidence map›Paper›PMID 35483084›Full record

ArticleJMIR public health and surveillance2022

Attitudes Toward the Global Allocation of Chinese COVID-19 Vaccines: Cross-sectional Online Survey of Adults Living in China.

Hanzhi Yu, Runming Du, Minmin Wang, Fengyun Yu, Juntao Yang, Lirui Jiao, Zhuoran Wang, Haitao Liu, Peixin Wu, Till Bärnighausen and 5 more

Open access · goldAbstract read
In one paragraph

Article in JMIR public health and surveillance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 5 countries.

Hanzhi Yu *School of Public Affairs, Zhejiang University, Hangzhou, China.ORCID 0000-0002-4588-0289
Runming Du *Department of Global Health, Peking University School of Public Health, Beijing, China.ORCID 0000-0003-2642-5552
Minmin Wang *Key Laboratory of Carcinogenesis and Translational Research, Laboratory of Genetics, Ministry of Education, Peking University Cancer Hospital & Institute, Beijing, China.ORCID 0000-0003-3213-2481
Fengyun Yu *State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0002-5607-1102
Juntao Yang *State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0003-1180-391X
Lirui JiaoColumbia University, New York, NY, United States.ORCID 0000-0002-2505-7447
Zhuoran WangChinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0001-5175-8645
Haitao LiuChinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0002-6184-1466
Peixin WuChinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0002-1288-0610
Till Bärnighausen *Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0002-4182-4212
Lan Xue *School of Public Policy and Management, Tsinghua University, Beijing, China.ORCID 0000-0002-5979-789X
Chen Wang *Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0001-7857-5435
Shannon McMahon *Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-8634-9283
Pascal Geldsetzer *Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA, United States.ORCID 0000-0002-8878-5505
Simiao Chen *Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0003-0555-2157
Chinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University · CNChan Zuckerberg Initiative (United States) · USColumbia University · USHeidelberg University · DETsinghua University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 vaccines are in short supply worldwide. China was among the first countries to pledge supplies of the COVID-19 vaccine as a global public product, and to date, the country has provided more than 600 million vaccines to more than 200 countries and regions with low COVID-19 vaccination rates. Understanding the public's attitude in China toward the global distribution of COVID-19 vaccines could inform global and national decisions, policies, and debates.

objectiveThe aim of this study was to determine the attitudes of adults living in China regarding the global allocation of COVID-19 vaccines developed in China and how these attitudes vary across provinces and by sociodemographic characteristics.

methodsWe conducted a cross-sectional online survey among adults registered with the survey company KuRunData. The survey asked participants 31 questions about their attitudes regarding the global allocation of COVID-19 vaccines developed in China. We disaggregated responses by province and sociodemographic characteristics. All analyses used survey sampling weights.

resultsA total of 10,000 participants completed the questionnaire. Participants generally favored providing COVID-19 vaccines to foreign countries before fulfilling domestic needs (75.6%, 95% CI 74.6%-76.5%). Women (3778/4921, 76.8%; odds ratio 1.18, 95% CI 1.07-1.32; P=.002) and those living in rural areas (3123/4065, 76.8%; odds ratio 1.13, 95% CI 1.01-1.27; P=.03) were especially likely to hold this opinion. Most respondents preferred providing financial support through international platforms rather than directly offering support to individual countries (72.1%, 95% CI 71%-73.1%), while for vaccine products they preferred direct provision to relevant countries instead of via a delivery platform such as COVAX (77.3%, 95% CI 76.3%-78.2%).

conclusionsAmong our survey sample, we found that adults are generally supportive of the international distribution of COVID-19 vaccines, which may encourage policy makers to support and implement the distribution of COVID-19 vaccines developed in China worldwide. Conducting similar surveys in other countries could help align policy makers' actions on COVID-19 vaccine distribution with the preferences of their constituencies.

Indexed as

COVID-19VaccinesAdultAttitudeChinaCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansSARS-CoV-2COVID-19 VaccinesVaccinesChinaCOVID-19COVID-19 vaccinescross-sectionalepidemiologyglobal allocationhealth policypandemicpublic attitudespublic healthsurveyvaccines

Identifiers

PMID35483084
PMCPMC9177168
OpenAlexW4225145120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.